
Illumina ILMN
$ 124.12
-2.21%
Quarterly report 2025-Q3
added 10-31-2025
Illumina P/B Ratio 2011-2026 | ILMN
Annual P/B Ratio Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.6 | 3.3 | 2.08 | 7.37 | - | 10 | 11.2 | 10.7 | 12.1 | - | 18.8 | 11.8 | 5.95 | 7.31 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.8 | 2.08 | 8.6 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 16.65 | - | $ 179 M | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 23.93 | -3.12 % | $ 665 M | ||
|
Agilent Technologies
A
|
7.78 | $ 113.27 | -1.39 % | $ 34.4 B | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.11 | -2.52 % | $ 1.98 B | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 1.59 | -2.72 % | $ 2.12 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 25.48 | -6.05 % | $ 20 B | ||
|
Personalis
PSNL
|
1.25 | $ 5.26 | -4.36 % | $ 312 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 19.91 | -9.15 % | $ 1.06 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 14.9 | -2.61 % | $ 451 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Trinity Biotech plc
TRIB
|
-375 | $ 0.61 | -1.21 % | $ 61.9 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 168.25 | 0.88 % | $ 8.34 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 57.54 | -2.72 % | $ 3.44 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
-135 | $ 82.57 | -0.66 % | $ 10.4 B | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 80.89 | -3.18 % | $ 5.46 B | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.96 | 1.5 % | $ 8.67 M | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 6.86 | -4.44 % | $ 286 M | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 410.67 | 0.22 % | $ 11.8 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.16 | -1.47 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 114.53 | 11.74 % | $ 9.45 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 255.97 | -1.39 % | $ 21.3 B | ||
|
NeoGenomics
NEO
|
1.77 | $ 9.18 | 1.72 % | $ 1.18 B | ||
|
Celcuity
CELC
|
53.4 | $ 119.79 | -0.24 % | $ 5.6 B | ||
|
National Research Corporation
NRC
|
22.5 | $ 15.0 | -10.93 % | $ 336 M | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.75 | -1.96 % | $ 440 M | ||
|
Natera
NTRA
|
7.52 | $ 194.2 | -2.98 % | $ 19.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 188.26 | -3.48 % | $ 20.9 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
4.02 | $ 2.73 | - | $ 58.9 M | ||
|
OpGen
OPGN
|
1.24 | - | -16.95 % | $ 1.54 M |